These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8776014)

  • 1. Therapeutic approaches to lysosomal storage diseases.
    Kaye EM
    Curr Opin Pediatr; 1995 Dec; 7(6):650-4. PubMed ID: 8776014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New prospects for the treatment of lysosomal storage diseases.
    Schiffmann R; Brady RO
    Drugs; 2002; 62(5):733-42. PubMed ID: 11929328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer approaches to the lysosomal storage disorders.
    Barranger JA; Rice EO; Swaney WP
    Neurochem Res; 1999 Apr; 24(4):601-15. PubMed ID: 10227692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.
    Hoogerbrugge PM; Brouwer OF; Bordigoni P; Ringden O; Kapaun P; Ortega JJ; O'Meara A; Cornu G; Souillet G; Frappaz D
    Lancet; 1995 Jun; 345(8962):1398-402. PubMed ID: 7760610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher's disease. Enzyme therapy is not enough.
    Grabowski GA
    Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gaucher's disease; current developments in the treatment of lysosomal metabolic disease].
    Hollak CE; Aerts JM; Goudsmit R
    Ned Tijdschr Geneeskd; 1991 Nov; 135(46):2162-4. PubMed ID: 1956441
    [No Abstract]   [Full Text] [Related]  

  • 8. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease.
    Schuening F; Longo WL; Atkinson ME; Zaboikin M; Kiem HP; Sanders J; Scott CR; Storb R; Miller AD; Reynolds T; Bensinger W; Rowley S; Gooley T; Darovsky B; Appelbaum F
    Hum Gene Ther; 1997 Nov; 8(17):2143-60. PubMed ID: 9414262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI; Pastores GM; Isola L; Giraldo P; Bueno Gómez J
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO; Barton NW
    Lipids; 1996 Mar; 31 Suppl():S137-9. PubMed ID: 8729108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state.
    Chan KW; Wong LT; Applegarth D; Davidson AG
    Bone Marrow Transplant; 1994 Aug; 14(2):327-30. PubMed ID: 7994251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone-marrow transplantation in severe Gaucher's disease.
    Rappeport JM; Ginns EI
    N Engl J Med; 1984 Jul; 311(2):84-8. PubMed ID: 6377066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal storage disorders: Morphologic appraisal in Indian population.
    Pradhan D; Varma N; Gami A; Hura KS; Mohanty SK
    J Cancer Res Ther; 2017; 13(3):442-445. PubMed ID: 28862206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.
    Nolta JA; Yu XJ; Bahner I; Kohn DB
    J Clin Invest; 1992 Aug; 90(2):342-8. PubMed ID: 1379609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gaucher's disease - an overview about a sphingolipidosis].
    Tamò R; Hochuli M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):209-214. PubMed ID: 30468119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
    Holley RJ; Wood SR; Bigger BW
    ACS Chem Neurosci; 2019 Jan; 10(1):18-20. PubMed ID: 30136572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.